LD-2 disclosure · 4th Quarter - Report
ASTELLAS PHARMA US, INC.
via ASTELLAS PHARMA US, INC.
Client
- Name
- ASTELLAS PHARMA US, INC.
- Location
- Illinois · United States of America
Registrant
- Firm
- ASTELLAS PHARMA US, INC.
- Description
- Pharmaceuticals
- Location
- Northbrook, Illinois, United States of America
Lobbying activities
4 issuesMedicare/Medicaid
Transparency Policy Issues, Medicare Part D, Coverage Gap, Rebate Reform, Out-of-Pocket Costs; H.R. 1825/S. 2821 PSA Screening for HIM Act; Issues related to IRA (Pub. L 117-169); Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills); H.R. 2666, MVP Act.
LobbyistsJONATHAN OEHMEN · AKSHAI DATTA
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Value of Prescription Drugs, Drug pricing, Biopharmaceutical Innovation and Patient Policy Issues (no specific bills); Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills); H.R. 6743, WARM Act of 2023; H.R. 1826/S. 2821, PSA Screening for HIM Act; H.R. 8223/S. 4246 Advancing Menopause and Mid-Life Womens Health Act; Issues related to Eye Screening and Access (no specific bills); Issues related to menopause; issues related to implementation of the Inflation Reduction Act.
LobbyistsJONATHAN OEHMEN · AKSHAI DATTA
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS) · Natl Institutes of Health (NIH)
Copyright/Patent/Trademark
Issues related to Bayh-Dole Act (Pub.L. 96-517).